Due to some similarities between SBA and colorectal cancer (CRC) in terms of molecular alterations and effective chemotherapy regimens, targeted therapies usually used in CRC, such as anti-epidermal growth factor receptor (EGFR) or anti-vascular endothelial growth factor (VEGF), were studied in advanced SBA. The gene discussed is EGFR; the disease is colorectal carcinoma.